Ocugen Inc. (NASDAQ: OCGN)
$1.95
+0.0400 ( +2.09% ) 4.7M
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Market Data
Open
$1.95
Previous close
$1.91
Volume
4.7M
Market cap
$501.84M
Day range
$1.88 - $1.98
52 week range
$0.35 - $2.11
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 35 | May 28, 2024 |
pre | Proxies and info statements | 34 | May 17, 2024 |
8-k | 8K-related | 31 | May 14, 2024 |
10-q | Quarterly Reports | 65 | May 14, 2024 |
8-k | 8K-related | 14 | May 10, 2024 |
8-k | 8K-related | 13 | Apr 29, 2024 |
10-k/a | Quarterly Reports | 15 | Apr 29, 2024 |
4 | Insider transactions | 1 | Apr 17, 2024 |
10-k | Annual reports | 97 | Apr 16, 2024 |
8-k | 8K-related | 14 | Apr 08, 2024 |